Table of Content

1 Bupivacaine Liposome Injectable Suspension Market Overview
1.1 Product Overview and Scope of Bupivacaine Liposome Injectable Suspension
1.2 Bupivacaine Liposome Injectable Suspension Segment by Type
1.2.1 Global Bupivacaine Liposome Injectable Suspension Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 20ml
1.2.3 10ml
1.3 Bupivacaine Liposome Injectable Suspension Segment by Application
1.3.1 Bupivacaine Liposome Injectable Suspension Sales Comparison by Application: (2021-2027)
1.3.2 Veterinary
1.3.3 Human
1.4 Global Bupivacaine Liposome Injectable Suspension Market Size Estimates and Forecasts
1.4.1 Global Bupivacaine Liposome Injectable Suspension Revenue 2016-2027
1.4.2 Global Bupivacaine Liposome Injectable Suspension Sales 2016-2027
1.4.3 Bupivacaine Liposome Injectable Suspension Market Size by Region: 2016 Versus 2021 Versus 2027

2 Bupivacaine Liposome Injectable Suspension Market Competition by Manufacturers
2.1 Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Manufacturers (2016-2021)
2.2 Global Bupivacaine Liposome Injectable Suspension Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Bupivacaine Liposome Injectable Suspension Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Bupivacaine Liposome Injectable Suspension Manufacturing Sites, Area Served, Product Type
2.5 Bupivacaine Liposome Injectable Suspension Market Competitive Situation and Trends
2.5.1 Bupivacaine Liposome Injectable Suspension Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Bupivacaine Liposome Injectable Suspension Players Market Share by Revenue
2.5.3 Global Bupivacaine Liposome Injectable Suspension Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Bupivacaine Liposome Injectable Suspension Retrospective Market Scenario by Region
3.1 Global Bupivacaine Liposome Injectable Suspension Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Bupivacaine Liposome Injectable Suspension Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Bupivacaine Liposome Injectable Suspension Market Facts & Figures by Country
3.3.1 North America Bupivacaine Liposome Injectable Suspension Sales by Country
3.3.2 North America Bupivacaine Liposome Injectable Suspension Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Bupivacaine Liposome Injectable Suspension Market Facts & Figures by Country
3.4.1 Europe Bupivacaine Liposome Injectable Suspension Sales by Country
3.4.2 Europe Bupivacaine Liposome Injectable Suspension Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Bupivacaine Liposome Injectable Suspension Market Facts & Figures by Region
3.5.1 Asia Pacific Bupivacaine Liposome Injectable Suspension Sales by Region
3.5.2 Asia Pacific Bupivacaine Liposome Injectable Suspension Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Bupivacaine Liposome Injectable Suspension Market Facts & Figures by Country
3.6.1 Latin America Bupivacaine Liposome Injectable Suspension Sales by Country
3.6.2 Latin America Bupivacaine Liposome Injectable Suspension Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Bupivacaine Liposome Injectable Suspension Market Facts & Figures by Country
3.7.1 Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales by Country
3.7.2 Middle East and Africa Bupivacaine Liposome Injectable Suspension Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Bupivacaine Liposome Injectable Suspension Historic Market Analysis by Type
4.1 Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Type (2016-2021)
4.2 Global Bupivacaine Liposome Injectable Suspension Revenue Market Share by Type (2016-2021)
4.3 Global Bupivacaine Liposome Injectable Suspension Price by Type (2016-2021)

5 Global Bupivacaine Liposome Injectable Suspension Historic Market Analysis by Application
5.1 Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Application (2016-2021)
5.2 Global Bupivacaine Liposome Injectable Suspension Revenue Market Share by Application (2016-2021)
5.3 Global Bupivacaine Liposome Injectable Suspension Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Pacira Pharmaceuticals
6.1.1 Pacira Pharmaceuticals Corporation Information
6.1.2 Pacira Pharmaceuticals Description and Business Overview
6.1.3 Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pacira Pharmaceuticals Product Portfolio
6.1.5 Pacira Pharmaceuticals Recent Developments/Updates

7 Bupivacaine Liposome Injectable Suspension Manufacturing Cost Analysis
7.1 Bupivacaine Liposome Injectable Suspension Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Bupivacaine Liposome Injectable Suspension
7.4 Bupivacaine Liposome Injectable Suspension Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Bupivacaine Liposome Injectable Suspension Distributors List
8.3 Bupivacaine Liposome Injectable Suspension Customers

9 Bupivacaine Liposome Injectable Suspension Market Dynamics
9.1 Bupivacaine Liposome Injectable Suspension Industry Trends
9.2 Bupivacaine Liposome Injectable Suspension Growth Drivers
9.3 Bupivacaine Liposome Injectable Suspension Market Challenges
9.4 Bupivacaine Liposome Injectable Suspension Market Restraints

10 Global Market Forecast
10.1 Bupivacaine Liposome Injectable Suspension Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Bupivacaine Liposome Injectable Suspension by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Bupivacaine Liposome Injectable Suspension by Type (2022-2027)
10.2 Bupivacaine Liposome Injectable Suspension Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Bupivacaine Liposome Injectable Suspension by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Bupivacaine Liposome Injectable Suspension by Application (2022-2027)
10.3 Bupivacaine Liposome Injectable Suspension Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Bupivacaine Liposome Injectable Suspension by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Bupivacaine Liposome Injectable Suspension by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Bupivacaine Liposome Injectable Suspension Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Bupivacaine Liposome Injectable Suspension Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Bupivacaine Liposome Injectable Suspension Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Bupivacaine Liposome Injectable Suspension Covered in This Study
Table 5. Global Bupivacaine Liposome Injectable Suspension Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Bupivacaine Liposome Injectable Suspension Sales Share by Manufacturers (2016-2021)
Table 7. Global Bupivacaine Liposome Injectable Suspension Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Bupivacaine Liposome Injectable Suspension Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Bupivacaine Liposome Injectable Suspension Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Bupivacaine Liposome Injectable Suspension Manufacturing Sites and Area Served
Table 11. Manufacturers Bupivacaine Liposome Injectable Suspension Product Type
Table 12. Global Bupivacaine Liposome Injectable Suspension Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Bupivacaine Liposome Injectable Suspension by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bupivacaine Liposome Injectable Suspension as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Bupivacaine Liposome Injectable Suspension Sales by Region (2016-2021) & (K Units)
Table 16. Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Region (2016-2021)
Table 17. Global Bupivacaine Liposome Injectable Suspension Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Bupivacaine Liposome Injectable Suspension Sales by Country (2016-2021) & (K Units)
Table 19. North America Bupivacaine Liposome Injectable Suspension Sales Market Share by Country (2016-2021)
Table 20. North America Bupivacaine Liposome Injectable Suspension Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Bupivacaine Liposome Injectable Suspension Revenue Market Share by Country (2016-2021)
Table 22. Europe Bupivacaine Liposome Injectable Suspension Sales by Country (2016-2021) & (K Units)
Table 23. Europe Bupivacaine Liposome Injectable Suspension Sales Market Share by Country (2016-2021)
Table 24. Europe Bupivacaine Liposome Injectable Suspension Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Bupivacaine Liposome Injectable Suspension Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Bupivacaine Liposome Injectable Suspension Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Bupivacaine Liposome Injectable Suspension Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Bupivacaine Liposome Injectable Suspension Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Bupivacaine Liposome Injectable Suspension Revenue Market Share by Region (2016-2021)
Table 30. Latin America Bupivacaine Liposome Injectable Suspension Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Bupivacaine Liposome Injectable Suspension Sales Market Share by Country (2016-2021)
Table 32. Latin America Bupivacaine Liposome Injectable Suspension Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Bupivacaine Liposome Injectable Suspension Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Bupivacaine Liposome Injectable Suspension Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Bupivacaine Liposome Injectable Suspension Revenue Market Share by Country (2016-2021)
Table 38. Global Bupivacaine Liposome Injectable Suspension Sales (K Units) by Type (2016-2021)
Table 39. Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Type (2016-2021)
Table 40. Global Bupivacaine Liposome Injectable Suspension Revenue (Million US$) by Type (2016-2021)
Table 41. Global Bupivacaine Liposome Injectable Suspension Revenue Share by Type (2016-2021)
Table 42. Global Bupivacaine Liposome Injectable Suspension Price (US$/Unit) by Type (2016-2021)
Table 43. Global Bupivacaine Liposome Injectable Suspension Sales (K Units) by Application (2016-2021)
Table 44. Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Application (2016-2021)
Table 45. Global Bupivacaine Liposome Injectable Suspension Revenue (Million US$) by Application (2016-2021)
Table 46. Global Bupivacaine Liposome Injectable Suspension Revenue Share by Application (2016-2021)
Table 47. Global Bupivacaine Liposome Injectable Suspension Price (US$/Unit) by Application (2016-2021)
Table 48. Pacira Pharmaceuticals Corporation Information
Table 49. Pacira Pharmaceuticals Description and Business Overview
Table 50. Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Product
Table 52. Pacira Pharmaceuticals Recent Developments/Updates
Table 53. Production Base and Market Concentration Rate of Raw Material
Table 54. Key Suppliers of Raw Materials
Table 55. Bupivacaine Liposome Injectable Suspension Distributors List
Table 56. Bupivacaine Liposome Injectable Suspension Customers List
Table 57. Bupivacaine Liposome Injectable Suspension Market Trends
Table 58. Bupivacaine Liposome Injectable Suspension Growth Drivers
Table 59. Bupivacaine Liposome Injectable Suspension Market Restraints
Table 60. Global Bupivacaine Liposome Injectable Suspension Sales Forecast by Type (2022-2027) & (K Units)
Table 61. Global Bupivacaine Liposome Injectable Suspension Sales Market Share Forecast by Type (2022-2027)
Table 62. Global Bupivacaine Liposome Injectable Suspension Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 63. Global Bupivacaine Liposome Injectable Suspension Revenue Market Share Forecast by Type (2022-2027)
Table 64. Global Bupivacaine Liposome Injectable Suspension Sales Forecast by Application (2022-2027) & (K Units)
Table 65. Global Bupivacaine Liposome Injectable Suspension Sales Market Share Forecast by Application (2022-2027)
Table 66. Global Bupivacaine Liposome Injectable Suspension Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 67. Global Bupivacaine Liposome Injectable Suspension Revenue Market Share Forecast by Application (2022-2027)
Table 68. Global Bupivacaine Liposome Injectable Suspension Sales Forecast by Region (2022-2027) & (K Units)
Table 69. Global Bupivacaine Liposome Injectable Suspension Sales Market Share Forecast by Region (2022-2027)
Table 70. Global Bupivacaine Liposome Injectable Suspension Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 71. Global Bupivacaine Liposome Injectable Suspension Revenue Market Share Forecast by Region (2022-2027)
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bupivacaine Liposome Injectable Suspension
Figure 2. Global Bupivacaine Liposome Injectable Suspension Market Share by Type in 2020 & 2027
Figure 3. 20ml Product Picture
Figure 4. 10ml Product Picture
Figure 5. Global Bupivacaine Liposome Injectable Suspension Market Share by Application in 2020 & 2027
Figure 6. Veterinary
Figure 7. Human
Figure 8. Global Bupivacaine Liposome Injectable Suspension Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Bupivacaine Liposome Injectable Suspension Market Size 2016-2027 (US$ Million)
Figure 10. Global Bupivacaine Liposome Injectable Suspension Sales 2016-2027 (K Units)
Figure 11. Global Bupivacaine Liposome Injectable Suspension Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Bupivacaine Liposome Injectable Suspension Sales Share by Manufacturers in 2020
Figure 13. Global Bupivacaine Liposome Injectable Suspension Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Bupivacaine Liposome Injectable Suspension Players: Market Share by Revenue in 2020
Figure 15. Bupivacaine Liposome Injectable Suspension Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Region (2016-2021)
Figure 17. Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Region in 2020
Figure 18. Global Bupivacaine Liposome Injectable Suspension Revenue Market Share by Region (2016-2021)
Figure 19. Global Bupivacaine Liposome Injectable Suspension Revenue Market Share by Region in 2020
Figure 20. U.S. Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Bupivacaine Liposome Injectable Suspension Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Bupivacaine Liposome Injectable Suspension by Type (2016-2021)
Figure 45. Sales Market Share of Bupivacaine Liposome Injectable Suspension by Application (2016-2021)
Figure 46. Sales Market Share of Bupivacaine Liposome Injectable Suspension by Application in 2020
Figure 47. Revenue Share of Bupivacaine Liposome Injectable Suspension by Application (2016-2021)
Figure 48. Revenue Share of Bupivacaine Liposome Injectable Suspension by Application in 2020
Figure 49. Manufacturing Cost Structure of Bupivacaine Liposome Injectable Suspension
Figure 50. Manufacturing Process Analysis of Bupivacaine Liposome Injectable Suspension
Figure 51. Bupivacaine Liposome Injectable Suspension Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed